• Urology Associates, P.C., First in Tennessee to Offer Targeted MRI/Ultrasound Fusion Biopsy

    Urology Associates, M.D., is proud to announce a powerful new Magnetic Resonance (MR) solution for analysis, planning and targeted biopsy of the prostate. This complete clinical MR solution for the prostate consists of DynaCAD for Prostate and the UroNav fusion biopsy system – a comprehensive solution which offers a cutting edge imaging option for many patients with elevated and/or rising PSA levels.

    Targeted MR/ultrasound biopsy is poised to become the new standard in prostate care, and Urology Associates, P.C., is pleased to be the first urology group in Tennessee to offer this powerful solution to our patients. UroNav fuses pre-biopsy MR images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions.

    The fusion of the MR and ultrasound images uses electromagnetic tracking, similar to your car’s GPS system; a tiny tracking sensor attached to the trans-rectal ultrasound probe generates a small, localized electromagnetic field that helps determine the location and orientation of the biopsy device. A sophisticated algorithm maintains the fusion of MR and ultrasound images, even when the patient moves.

    “We are confident that this new technology will bring new hope to patients and provide our healthcare providers with the latest technology to identify and target suspicious prostate lesions,” explains David Morris, MD, urologist with Urology Associates, P.C.

  • We have joined Twitter!

    You will now be able to keep up with the UA family and the latest and greatest treatment trends by following us on Twitter. Follow our page today! @UA_Nashville

  • Urology Associates is growing and changing!

    The practice formerly known as the Center for Urological Treatment (CUT) has now joined Urology Associates. We are glad to be welcoming Dr. Tara Allen, Dr. Howard Aubert, Dr. L. Dean Knoll and Dr. Mitchell Wiatrak to the Urology Associates family. They bring more than 50 years of combined experience to the practice.

    Urology Associates is also proud to announce that Dr. Tom Jayram and Dr. Corinne Puzio will be joining our practice this summer as well. Dr. Jayram will be practicing at the Charlotte Avenue location. Meanwhile, Dr. Puzio will be practicing at the Skyline and Springfield locations. Dr. Thomas Landon and his family have decided to relocate to St. Louis. He will be missed.

    Patients will now be seeing Dr. M. Leon Seard at the Summit office. Dr. Seard, Dr. Ezell and Dr. Hawkins will be working together to provide comprehensive and compassionate urological care to men and women.

    We have added more convenient locations! Urology Associates now has a permanent location in Dickson, TN and satellite clinics in Ashland City, TN, Spring Hill, TN, and Bowling Green, KY.

    Learn more about all of Urology Associates’ providers by clicking the “Our Providers” tab at the top of the screen. You can also find all of our convenient locations by clicking on the “Locations” link at the top of the screen.

    Urology Associates is always looking for innovative ways to improve patient care. For this reason, we are improving our X-Ray department. All X-Rays are now digital! This change makes the imaging process more efficient for our patients.

  • Join us for an evening of yoga.

    Urology Associates’ Women’s Institute for Sexual Health (WISH) invites you to an evening of yoga! We will be hosting classes on July 24 and August 21 from 5:30 to 6:45 PM with guest yoga instructor Jennifer Derryberry Mann. This class is suitable for all levels and abilities and is free to all patients. Please bring a yoga mat or towel and water. Be sure to wear comfortable clothing that allows you to move freely. If you are interested please RSVP with Melinda Blake at 615-250-9265 or mrblake@ua-pc.com by the Tuesday before the class. Please hurry since spaces are limited!

  • Advanced Therapeutics Center

    The Advanced Therapeutics Center of Urology Associates is focused on delivering high quality care utilizing cutting edge therapies that will be complimentary with the medicines already delivered by your care team. This addition to our website is comprised of information on clinical trials, bone health, men’s health, Provenge & Xofigo, Penile Rehab, and Advanced Prostate Cancer. Click on the Contact Us link within the Advanced Therapeutics Tab to identify whom the correct contact is for your specific need, and schedule your appointment today!

  • Urology Associates Charlotte Location is Now Even Easier to Visit

    Urology Associates’ Charlotte Ave. location is now even more convenient with the brand new 31st/28th
    street connector bridge opening October 2nd. This connector bridge will give patients a quicker route to Charlotte Ave. from the West End Centennial Park area.

    Along with the new route, Urology Associates is beautifying Charlotte Ave. with new landscaping, stoplights, bus stops, and bike racks, giving our patients more convenient ways to keep appointments while continuing to be at the forefront of transforming Charlotte Ave. into an up and coming area in the greater Nashville area.

  • Early Detection of Prostate Cancer Saves Lives

    The U.S. Preventive Services Task Force has recommended healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening.

    • This decision is being made by a panel that does not include urologists or oncologists. No new research has been cited that would call for this drastic change in prostate cancer testing recommendations since the USPSTF considered this issue in 2009.

    • In 2009, this same task force tried unsuccessfully to eliminate mammograms for women ages 40-49 and recommended against teaching women to do breast self exams, which Congress rejected after public outcry.

  • The Data

    The most recently updated study, The Göteborg Randomized Population-based Prostate Cancer Screening Trial,1 2 found that with screening, deaths from prostate cancer dropped 44% over a 14-year period, compared with men who did not undergo screening, and that prostate cancer screening efficiency was similar to other cancers.

    Early detection is critical to the success of prostate cancer treatments.

  • Take Action

    Voice concern to task force chair, Dr. Virginia Moyer, at moyer@bcm.edu and your federal policymakers today!